Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

16636

Millipore

UTI ChromoSelect Agar, modified

NutriSelect® Plus, suitable for microbiology

Synonyme(s) :

Urinary Tract Infection Agar, modified

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Code UNSPSC :
41171606
Nomenclature NACRES :
NA.85

Stérilité

non-sterile

Niveau de qualité

200

Forme

powder

Durée de conservation

limited shelf life, expiry date on the label

Composition

agar, 15 g/L
beef extract, 4 g/L
casein enzymic hydrolysate, 4 g/L
chromogenic mixture, 12.44 g/L
peptic digest of animal tissue, 18 g/L

Fabricant/nom de marque

NutriSelect® Plus

pH final

7.2±0.3 (25 °C)

Application(s)

clinical testing
clinical testing
environmental
food and beverages
veterinary
microbiology

Température de stockage

2-8°C

Adéquation

nonselective and differential for Enterococcus spp.
nonselective and differential for Escherichia coli
nonselective and differential for Klebsiella spp.
nonselective and differential for Proteus spp.
nonselective and differential for Pseudomonas spp.
nonselective and differential for Staphylococcus spp.
nonselective and differential for coliforms
nonselective and differential for enterobacteriaceae

Catégories apparentées

Description générale

Urinary tract infection (UTI) ChromoSelect Agar is chromogenic differential medium for identification, differentiation, and conformation of enteric bacteria from specimens such as urine, water, or food which may contain large number of Proteus species as well as potentially pathogenic Gram-positive organisms. Based on these characteristics, modified UTI ChromoSelect Agar is suggested for use in place of MacConkey Agar.

Application

Urinary tract infection (UTI) ChromoSelect Agar, modified has been used in the cell culture of Escherichia coli. It has also been used in the culturing of Klebsiella pneumoniae and Escherichia coli to plate mouse thigh muscle homogenates for bacterial count.

Notes préparatoires

Suspend 55.4 g in 1 litre distilled water. Boil to dissolve the medium completely. Sterilize by autoclaving at 1 bar pressure (121°C) for 15 minutes. Cool to 50°C and pour into sterile petri plates.

Autres remarques

Chromogenic medium for detecting and identifying Enterobacteria, Proteus species, and certain potentially pathogenic Gram-positive organisms.

Note de bas de page

We offer two media types: the superior granulated GranuCult® and the cost-efficient powdered NutriSelect® culture media, depending on your needs.
The designations basic, plus, or prime are added to indicate the quality control level, from basic quality control to standard QC plus to prime for full regulatory compliance.

Informations légales

GRANUCULT is a registered trademark of Merck KGaA, Darmstadt, Germany
NutriSelect is a registered trademark of Merck KGaA, Darmstadt, Germany

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Équipement de protection individuelle

Eyeshields, Gloves, type N95 (US)

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number
BCCM1993
BCCL6172
BCCK7875
BCCH8666
BCCD9576

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

M. Pezzlo
Clin. Microbiol. Reviews, 1, 168-168 (1998)
M P Friedman et al.
Journal of clinical microbiology, 29(11), 2385-2389 (1991-11-01)
Random urine samples from hospitalized patients (n = 550) and seeded sterile filtered urine samples (n = 730) were used to test a membrane filtration technique, Qualture (Future Medical Technologies International, Inc., West Palm Beach, Fla.), for the detection and
Yang Yu et al.
The Journal of antimicrobial chemotherapy, 74(1), 87-95 (2018-10-23)
The emergence of NDM- and MCR-1-co-producing Escherichia coli has compromised the use of carbapenems and colistin, which are critically important in clinical therapy, and represents a severe threat to public health worldwide. Here, we demonstrate synergism of colistin combined with
Willames M B S Martins et al.
mSphere, 5(5) (2020-10-09)
This study provides the genomic characterization and clinical description of bloodstream infections (BSI) cases due to ST15 KPC-2 producer Klebsiella pneumoniae Six KPC-K. pneumoniae isolates were recovered in 2015 in a tertiary Brazilian hospital and were analyzed by whole-genome sequencing
Muhammad Usman Qamar et al.
Pakistan journal of pharmaceutical sciences, 32(5(Supplementary)), 2305-2309 (2020-01-03)
Metallo-β-lactamase (MBL) producing Escherichia coli are an emerging and serious threat to public health sector around the globe. MBL are spreading via plasmids to the host pathogens and produce resistance against carbapenems and left limited or no treatment option. Therefore

Articles

Pseudomonas Media and Tests

An article concerning the detection, identification, differentiation, and cultivation of Pseudomonas species.

Pseudomonas Media and Tests

An article concerning the detection, identification, differentiation, and cultivation of Pseudomonas species.

Pseudomonas Media and Tests

An article concerning the detection, identification, differentiation, and cultivation of Pseudomonas species.

Pseudomonas Media and Tests

An article concerning the detection, identification, differentiation, and cultivation of Pseudomonas species.

Afficher tout

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique